Fennec Pharmaceuticals Inc.(简称Fennec制药)近日披露,由亚利桑那大学癌症中心主导的一项研究者发起研究(ISS)即将启动。该研究旨在探索公司核心疗法在临床实践中的潜在应用价值。
Fennec Pharmaceuticals Inc.(简称Fennec制药)近日披露,由亚利桑那大学癌症中心主导的一项研究者发起研究(ISS)即将启动。该研究旨在探索公司核心疗法在临床实践中的潜在应用价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.